These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2248955)

  • 41. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X.
    Ruf W
    Biochemistry; 1994 Sep; 33(38):11631-6. PubMed ID: 7918377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the kinetics of factor X activation by tissue factor-factor VIIA.
    Nemerson Y
    Haemostasis; 1996 Oct; 26 Suppl 4():98-101. PubMed ID: 8979116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
    Sichler K; Banner DW; D'Arcy A; Hopfner KP; Huber R; Bode W; Kresse GB; Kopetzki E; Brandstetter H
    J Mol Biol; 2002 Sep; 322(3):591-603. PubMed ID: 12225752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of human factor VIII in factor X activation.
    Hultin MB
    J Clin Invest; 1982 Apr; 69(4):950-8. PubMed ID: 6804496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
    Walsh PN; Bradford H; Sinha D; Piperno JR; Tuszynski GP
    J Clin Invest; 1984 May; 73(5):1392-9. PubMed ID: 6609171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.
    Imamura T; Tanase S; Hamamoto T; Potempa J; Travis J
    Biochem J; 2001 Jan; 353(Pt 2):325-31. PubMed ID: 11139397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor.
    Thomsen MK; Wildgoose P; Nilsson P; Hedner U
    Pharmacol Toxicol; 1993 Sep; 73(3):127-32. PubMed ID: 7903449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X.
    Kurosawa S; Matsuda M; Aoki N
    Thromb Res; 1984 Mar; 33(6):595-606. PubMed ID: 6609450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor.
    Sakai T; Lund-Hansen T; Thim L; Kisiel W
    J Biol Chem; 1990 Feb; 265(4):1890-4. PubMed ID: 2298729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
    Sanders NL; Bajaj SP; Zivelin A; Rapaport SI
    Blood; 1985 Jul; 66(1):204-12. PubMed ID: 3873968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor.
    Telgt DS; Macik BG; McCord DM; Monroe DM; Roberts HR
    Thromb Res; 1989 Dec; 56(5):603-9. PubMed ID: 2626745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
    Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
    Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of factor IX bound to cultured bovine aortic endothelial cells.
    Stern DM; Drillings M; Kisiel W; Nawroth P; Nossel HL; LaGamma KS
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):913-7. PubMed ID: 6608105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cooperative interaction of divalent metal ions, substrate, and tissue factor with factor VIIa.
    Butenas S; Lawson JH; Kalafatis M; Mann KG
    Biochemistry; 1994 Mar; 33(11):3449-56. PubMed ID: 8136382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
    Hoffman M; Monroe DM; Roberts HR
    Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
    Liebman HA; Furie BC; Furie B
    J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.